Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System

NCT02235857 is registered in ClinicalTrials.gov with Kaneka Medical America LLC as lead sponsor.

NCT NCT02235857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02235857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System
Lead sponsor
Kaneka Medical America LLC
Phase
Not applicable
Overall status
Recruiting
Start date
May 3, 2015
Completion date
September 30, 2029
Enrollment
35 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental glomerulosclerosis